Registration is now open for the annual invasive #lobular breast cancer symposium (ilcsymposium.com) which will take place in Leuven, Belgium, this year on September 23-25! Register now as places are limited. @OncoAlert
Christopher Fletcher, MD, @DanaFarber has received the #AACR24 James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research for discoveries transforming the cancer pathology field and establishing innovative therapies.
ms.spr.ly/6017c4cES
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer. Read the highlights 👉 annalsofoncology.org/article…
Hi all! Feeling great in neuro ICU at #RPAH/@SydneyLHD. Thanks so much to my friend & colleague Dr Brindha Shivalingam & team for meeting with my wife Dr Katie Nicoll & @ProfGLongMIA yesterday & for operating on me today! Thanks to friends & colleagues around world & @MelanomaAus
Day 75/250 of my "tour" of @BCRFcure funded researchers... sometimes you get a 2-for-1... Dr. Schnitt and Dr. Tung, both at @DanaFarber, "are analyzing blood and tumor specimens collected from INFORM participants to better understand... 1/2 bcrf.org/researchers/stuart-…
Patient presents with a 8 mm palpable breast mass. Diagnosis? What is the most common molecular finding for this entity? Answer and pearls in the comments! #PathTwitter#MedEd#breastpath#pathology
I am deeply honored to announce that I have been appointed to succeed my mentor and teacher, Dr Helmut Rennke, as the next Chief of Renal Pathology @BWHPath @BWHkidney. I can only attempt to fill these massive shoes of a true giant and pioneer in our field.
Incredible lecture by @LANewmanMD who is dedicated to understanding and improving disparities in care and outcomes we see for our breast cancer patients; what an incredible way to honor the memory of Dr. Carolyn Kaelin!
@DFCI_BreastOnc#bcsm
@stolaney1@DrHBurstein@AnnPartridgeMD@nlinmd@elmayermd - our work looking at racial differences in the immune response to breast cancer is a finalist for the BRIght futures prize. Can we count on your vote? (And spread the word😊)
We have three impressive cancer-related research projects participating in the BRIght Futures Prize competition. The team with the most votes will receive a $100,000 award to further their work. Learn more and vote NOW through Oct. 7: brightfuturesprize.org
Thanks for sharing your work and expertise with us @LANewman - a phenomenal way to resume our Carolyn Kaelin Visiting Professorship @BrighamSurgery@DFCI_BreastOnc
Dr. @SchnittStuart covering Updates on Lobular Carcinoma In Situ Classification and Management … WATCH OUT for invasive lobular carcinoma with aberrant e-Cadherin staining!
Are you in Basel for #ECP2022? join this talk by Drs. @SchnittStuart@JudithSandbank on practical implications of using #AI in breast #pathology, looking at real world cases reviewed with AI and findings from recent clinical studies. See you at our booth (#1)! @ESP_Pathology